Figure Technology Solutions, Inc.
FIGR Nasdaq Loan Brokers Financials FY2023βFY2025
What Figure Technology Solutions, Inc. does
No business description yet.
- Legal name
- Figure Technology Solutions, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 16, 2026
- Accession Β· CIK
- 0002064124-26-000009
0002064124
Revenue and margins
Figure Technology Solutions, Inc. had $507M of revenue in fiscal 2025, up 48.7% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Figure Technology Solutions, Inc. returned $0.0M to shareholders in fiscal 2025. The diluted share count rose 95.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Figure Technology Solutions, Inc. can carry it.
| Fiscal year end | FY23 | FY24 | FY25 |
|---|---|---|---|
| Cash and short-term investments | $176M | $290M | $1.2B |
| Debt incl. finance leases | β | $473M | $557M |
| Debt / equity | β | 1.3x | 0.5x |
| Current ratio | β | 1.4x | 2.2x |
| Quick ratio | β | 1.4x | 2.2x |
| Total assets | β | $1.2B | $2.3B |
| Total liabilities | β | $796M | $1.1B |
| Shareholders' equity | $222M | $355M | $1.2B |
| Net debt (β = net cash) | β | $184M | β$641M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 3 | β / 4 | 5 / 8 |
| Accruals ratio | β | 12.4% | 4.1% |
| Altman Z'' | β | 0.92 | 4.15 |
3 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Income statement | |||
| Revenue | $210M | $341M | $507M |
| Research and development | $49.2M | $62.7M | $64.9M |
| Operating income | β$49.4M | $9.2M | $118M |
| Pretax income | β$52.3M | $22.1M | $114M |
| Income tax | $0.1M | $2.2M | β$20.6M |
| Net income | β$47.9M | $17.2M | $134M |
| Net income to common | β$47.9M | $0.0M | $62.0M |
| Diluted EPS | β$0.93 | $0.00 | $0.44 |
| Diluted shares | 0.05B | 0.07B | 0.14B |
| Cash flow | |||
| Cash from operations | β$33.4M | β$127M | $62.6M |
| Stock-based compensation | $13.5M | $38.7M | $62.4M |
| Share buybacks | $0.0M | $1.0M | $0.0M |
| Dividends and buybacks | $0.0M | $1.0M | $0.0M |
| Balance sheet | |||
| Cash and short-term investments | $176M | $290M | $1.2B |
| Total debt | β | $473M | $557M |
| Current assets | β | $855M | $1.9B |
| Current liabilities | β | $626M | $846M |
| Total assets | β | $1.2B | $2.3B |
| Total liabilities | β | $796M | $1.1B |
| Preferred stock | β | β | $0.0M |
| Shareholders' equity | $222M | $355M | $1.2B |
| Margins | |||
| Operating margin | β23.6% | 2.7% | 23.2% |
| Net margin | β22.9% | 5.0% | 26.4% |
| Returns | |||
| Return on capital | β | 1.5% | 20.0% |
| Return on capital employed | β | 1.7% | 8.0% |
| Return on equity | β21.6% | 6.0% | 16.9% |
| Return on assets | β | 1.5% | 7.7% |
| Return on tangible equity | β21.6% | 0.0% | 5.0% |
| Growth | |||
| Revenue growth | β | 62.7% | 48.7% |
| Net income growth | β | β | 677.6% |
| Share count change | β | 41.6% | 95.2% |
| Financial health | |||
| Debt / equity | β | 1.3x | 0.5x |
| Current ratio | β | 1.4x | 2.2x |
| Quick ratio | β | 1.4x | 2.2x |
| Capital allocation | |||
| Stock comp / revenue | 6.4% | 11.4% | 12.3% |
| Quality scores | |||
| Piotroski F-score | β | β | 5.0 |
| Altman Z'' | β | 0.9 | 4.1 |
| Accruals ratio | β | 12.4% | 4.1% |
Source: SEC EDGAR XBRL filings (CIK 0002064124). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.